• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过眼部途径进行多肽药物的全身递送。

Systemic delivery of polypeptide drugs through ocular route.

作者信息

Chiou G C

机构信息

Institute of Ocular Pharmacology, Texas A&M University Health Science Center, College Station.

出版信息

J Ocul Pharmacol. 1994 Spring;10(1):93-9. doi: 10.1089/jop.1994.10.93.

DOI:10.1089/jop.1994.10.93
PMID:8207348
Abstract

Because of rapid developments in biotechnology, numerous peptides are now available for clinical treatment of various diseases. In order to avoid parenteral injections, alternative routes of drug administration have been investigated. Among them, the ocular route seemed to be the most feasible one because a) it could deliver precise doses of drugs just like injections; b) it was much easier and less expensive to administer eyedrops than an injection; c) the rate of systemic absorption through the ocular route was as fast as an injection; d) eye tissues were much less sensitive to the development of immunological reactions than other tissues; e) the drug absorbed via the ocular route would avoid the first passage through hepatic circulation to reach the sites of action before liver metabolism; and f) no tolerance and ocular side effects could be detected after long-term (three months) daily administration of insulin eyedrops.

摘要

由于生物技术的迅速发展,现在有许多肽可用于各种疾病的临床治疗。为了避免肠胃外注射,人们研究了药物给药的替代途径。其中,眼部给药途径似乎是最可行的,因为:a)它可以像注射一样精确给药;b)滴眼药水比注射更容易且成本更低;c)通过眼部途径的全身吸收速率与注射一样快;d)眼组织对免疫反应的发生比其他组织敏感得多;e)通过眼部途径吸收的药物将避免首先通过肝循环,在肝脏代谢之前到达作用部位;f)长期(三个月)每日使用胰岛素眼药水后未检测到耐受性和眼部副作用。

相似文献

1
Systemic delivery of polypeptide drugs through ocular route.通过眼部途径进行多肽药物的全身递送。
J Ocul Pharmacol. 1994 Spring;10(1):93-9. doi: 10.1089/jop.1994.10.93.
2
Adjustment of blood sugar levels with insulin and glucagon eyedrops in normal and diabetic rabbits.
J Ocul Pharmacol. 1990 Fall;6(3):233-41. doi: 10.1089/jop.1990.6.233.
3
Feasibility of glucagon eyedrops for clinical use in hypoglycemia.胰高血糖素滴眼液用于临床低血糖症的可行性。
J Ocul Pharmacol Ther. 1995 Fall;11(3):279-82. doi: 10.1089/jop.1995.11.279.
4
Systemic absorption of oxytocin and vasopressin through eyes in rabbits.兔眼对催产素和血管加压素的全身吸收。
J Ocul Pharmacol. 1991 Winter;7(4):351-9. doi: 10.1089/jop.1991.7.351.
5
Chronic systemic delivery of insulin through the ocular route.通过眼部途径进行胰岛素的慢性全身给药。
J Ocul Pharmacol. 1993 Spring;9(1):85-90. doi: 10.1089/jop.1993.9.85.
6
Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog.将胰岛素和胰高血糖素局部应用于大鼠和一只糖尿病犬的眼部后的全身吸收情况。
J Ocul Pharmacol Ther. 1995 Fall;11(3):283-95. doi: 10.1089/jop.1995.11.283.
7
Systemic delivery of polypeptide drugs through ocular route.多肽药物经眼部途径的全身给药
Annu Rev Pharmacol Toxicol. 1991;31:457-67. doi: 10.1146/annurev.pa.31.040191.002325.
8
Alternative delivery of insulin via eye drops.通过眼药水进行胰岛素的替代给药。
Diabetes Technol Ther. 2005 Oct;7(5):695-8. doi: 10.1089/dia.2005.7.695.
9
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.聚氧乙烯化非离子表面活性剂及其在局部眼部给药中的应用。
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1663-73. doi: 10.1016/j.addr.2008.09.002. Epub 2008 Sep 20.
10
Delivery of systemic regular insulin via the ocular route in cats.通过眼部途径在猫体内递送全身性常规胰岛素。
J Ocul Pharmacol Ther. 1995 Winter;11(4):565-73. doi: 10.1089/jop.1995.11.565.

引用本文的文献

1
Design and Evaluation of Ophthalmic Thermosensitive In Situ Gel of Compound Salvia.复方丹参眼用温敏原位凝胶的设计与评价。
AAPS PharmSciTech. 2024 Aug 20;25(7):191. doi: 10.1208/s12249-024-02913-8.
2
Intraocular administration of tetramethylpyrazine hydrochloride to rats: a direct delivery pathway for brain targeting?盐酸川芎嗪经大鼠眼内给药:脑靶向的直接递送途径?
Drug Deliv. 2019 Dec;26(1):841-848. doi: 10.1080/10717544.2019.1650849.
3
A comprehensive insight on ocular pharmacokinetics.关于眼部药代动力学的全面见解。
Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2.
4
Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).醛糖还原酶、眼部糖尿病并发症与局部 Kinostat(®)的研发。
Prog Retin Eye Res. 2016 Sep;54:1-29. doi: 10.1016/j.preteyeres.2016.04.006. Epub 2016 Apr 19.